The largest database of trusted experimental protocols

8 protocols using lipopolysaccharides (lps)

1

Plasma Biomarkers in HIV-infected Individuals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma was isolated from blood samples collected into BD Vacutainer tubes and stored in endotoxin-free cryovials at −80°C. Behavioral data and blood samples typically were collected on the same day (range=0–17 intervening days). Enzyme-linked immunosorbent assays (ELISA) were used to quantify LPS (MyBioSource, San Diego, CA), LBP (Hycult Biotech, Wayne, PA), sCD14, and sCD163 (R&D Systems, Minneapolis, MN) following manufacturer instructions. ELISA tests were performed in duplicate, and samples with coefficient of variation ≥ 20% were excluded from further analysis. Percentages of samples exceeding this threshold by biomarker were as follows: 0% for LPS; 8% for LBP; 6% for sCD14; and 6% for sCD163. For HIV-infected participants, HCV status was determined at baseline by antibody test followed by HCV RNA testing for confirmation of reactive antibody results. HCV testing was not performed in controls due to resource limitations.
+ Open protocol
+ Expand
2

Plasma Biomarker ELISA Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma ZO-1 (Catalog #: MBS706368, MyBioSource, San Diego, CA), LPS (Catalog #: MBS266722, MyBioSource, San Diego, CA), sCD14 (Catalog #: RK01060, Abyntek Biopharma, Vizcaya, Spain), and IL-1β (Catalog #: MBS2510385, MyBioSource, San Diego, CA) were measured using commercially available ELISA kits according to the manufacturers’ instructions. Circulating human anti-β-lactoglobulin antibody levels (IgG isotypes) were assayed using a validated home-made ELISA protocol as detailed below. All the plasma samples were measured in blind duplicates for each biomarker. For all protocols, absorbance at 450 nm with 570 nm correction was measured in a microplate reader, and corrected absorbance was interpolated in each standard curve to determine the concentrations (Sigma Plot).
+ Open protocol
+ Expand
3

Serum Biomarkers After Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum was collected from blood samples obtained after 2 days poststroke. ELISA assays were used to determine IGF (Insulin‐like Growth Factor)‐1 (R&D Laboratories), IGFBP‐3 (Crystal Chem), 17β‐estradiol, intestinal fatty acid binding protein (iFABP), LPS (My Biosource), following the manufacturer's protocol.
+ Open protocol
+ Expand
4

Quantifying Endotoxin and Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected into endotoxin-free tubes, processed, and stored at −80 °C. Commercially available enzyme-linked immunosorbent assays for LPS (MyBiosource), sCD14 (Enzo LifeSciences), and EndoCAb (Hycult) were performed in duplicate following manufacturer instructions. Data were available for 18/21 participants for LPS and 20/21 participants for sCD14 and EndoCAb.
+ Open protocol
+ Expand
5

Quantifying Stress Biomarkers in Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum concentrations of LPS (MBS700021; MyBioSource, San Diego, CA, USA), CORT (KA0468; Abnova, Neihu District, Taipei City, Taiwan), CRH (MBS265444; MyBioSource), ACTH (MBS2700344; MyBioSource), IFN-γ (551,866; BD Bioscience, Franklin Lakes, NJ, USA), and IL-6 (555,240; BD Bioscience) were measured using ELISA kits according to the manufacturer’s protocols.
+ Open protocol
+ Expand
6

Quantification of Intestinal Immunoglobulins

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify luminal Igs, small intestines and colon were cut open longitudinally and mucus and feces were scrapped out and suspended into 1ml of PBS. Luminal content were spun at 8000g for 5 minutes and the supernatant collected and stored at −80°C. LPS (MyBiosource), sIgA (Cloud-Clone Corp.), IgA (Bethyl), IgM (Bethyl), IgG (Bethyl) and Calprotectin (S100A8/S100A9 Heterodimer Duoset; R&D systems) concentrations were measured by ELISAs in the serum or luminal content according to the manufacturer instructions. For luminal Igs measurement, concentration was normalized to the mucus weight. Murine serum Zonulin concentrations were measured by using a mouse Zonulin ELISA kit (MyBioSource).
+ Open protocol
+ Expand
7

Evaluation of LPS-Induced Metabolic Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS (Escherichia coli 055:B5) were obtained from Aladdin (Beijing, China). De Man, Rogosa, and Sharpe (MRS) was from Solarbio Ltd. (Solarbio, Beijing, China). Total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ALT, AST, MDA, T-AOC, SOD, GSH-Px, CAT, TNF-α, transforming growth factor (TGF)-β, IL-1β, IL-6, IL-17, IL-10, IL-22, and LPS kits were obtained from MY BioSource Co., Ltd. (San Diego, CA, USA).
+ Open protocol
+ Expand
8

Plasma Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma insulin (Millipore, Burlington, MA, USA) and lipopolysaccharide (LPS, MyBioSource, San Diego, CA, USA) concentrations were measured using rat/mouse ELISA kits. F2-isoprostane levels were measured by extraction of isoprostanes from plasma samples, adding a mixture of F2 isoprostanes as internal standard (Concordia University, Montreal, QC, Canada) for mass spectrometric quantification [27 (link),28 (link)]. Plasma levels of triglyceride (TG) and total cholesterol (TC) were assessed using commercial kits (Randox Laboratories, Crumlin, UK). Lipid peroxidation was estimated by measuring plasma malondialdehyde (MDA) concentration by HPLC as previously described [29 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!